Tumor Budding Significance as a Biomarker for Clinicopathology and Prognostic Evaluation in Gynecological Malignancy: A Bayesian Meta-Analysis

Key Points

• The aim is to assess the significance of tumor budding as a prognostic biomarker in gynecological malignancies.
• Conducted a Bayesian meta-analysis of existing literature
• Evaluated the association between tumor budding and clinicopathological features
• Assessed the prognostic implications of tumor budding in patients with gynecological malignancy
• Tumor budding shows a significant association with clinicopathological features
• Strong correlation with worse prognosis in gynecological malignancies
• Findings suggest that tumor budding could inform clinical assessments

Abstract